3401.T
Latest Trade
2,127.00JPYChange
17.00(+0.81%)Volume
567,700Today's Range
-
2,138.0052 Week Range
-
2,211.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 2,110.00 |
|---|---|
Open | 2,098.00 |
Volume | 567,700 |
3M AVG Volume | 17.86 |
Today's High | 2,138.00 |
Today's Low | 2,095.00 |
52 Week High | 2,211.00 |
52 Week Low | 1,652.00 |
Shares Out (MIL) | 191.83 |
Market Cap (MIL) | 417,682.30 |
Forward P/E | 10.57 |
Dividend (Yield %) | 2.84 |
Teijin And Neurosigma Enter Into Exclusive License Agreement
Continental Structural Plastics Acquires Ami Stamping, Manchester Operations
Teijin Ltd - To Sell Entire Stake In Consolidated Subsidiaries Of Teijin Film Solutions Limited (“Tfs”) And P.T. Indonesia Teijin Film Solutions (“Itfs”), That Operate Polyester Film Businesses
TEIJIN LIMITED is a Japan-based company engaged in aramid, carbon fiber, resin, composite molding material, fiber, medicine, and information technology (IT) business. The Company operates in two business segments. The Materials segment is involved in the manufacture and sale of aramid fibers, carbon fibers, polycarbonate resins, polyester films, polyester fibers, textile products, and composite molding materials. The Healthcare segment is involved in the manufacture and sale of pharmaceuticals and medical devices, as well as the provision of home medical services. The Company is also engaged in IT related business, such as the operation and development of information systems, the maintenance and engineering business, as well as the design and sale of plants and equipment.
Industry
Textiles - Non Apparel
Contact Info
Kasumigaseki Common Gate West Tower
3-2-1, Kasumigaseki
+81.3.35064529
https://www.teijin.co.jp/Executive Leadership
Jun Suzuki
Executive President, Chief Executive Officer, Representative Director
Kazuhiro Yamamoto
Executive Vice President, Chief Financial Officer, Representative Director
Yasumichi Takesue
Senior Managing Executive Officer, Director
Hiroshi Uno
Senior Managing Executive Officer, Director
Yoshihisa Sonobe
Managing Executive Officer, Director
Price To Earnings (TTM) | 13.61 |
|---|---|
Price To Sales (TTM) | 0.47 |
Price To Book (MRQ) | 1.00 |
Price To Cash Flow (TTM) | 4.84 |
Total Debt To Equity (MRQ) | 98.23 |
LT Debt To Equity (MRQ) | 58.96 |
Return on Investment (TTM) | 4.69 |
Return on Equity (TTM) | 3.21 |
* Says co and Teijin Limited would terminate the exclusive licensing agreement signed in 2009, regarding the development and marketing of SB623 for stroke treatment in Japan
* TEIJIN TO INVEST 35 BILLION YEN TO BUILD CARBON FIBER PLANT IN U.S. -NIKKEI Source text: (http://s.nikkei.com/2Al5U6z) Further company coverage:
* Says it will merge with a Tokyo-based fiber consolidated subsidiary
* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I
* Says it lowered the conversion price for 2018 due euro-yen denominated convertible bonds to 2,026 yen per share, from 2,035.7 yen per share, after Oct. 1
* Merz and Teijin announce partnership to bring Xeomin (Incobotulinumtoxina) to Japan
* Says it will transfer rights and obligations, including inventories, investment securities and capital invested into group company, to wholly owned unit TEIJIN FRONTIER CO., LTD.
* Says it entered into co-development and license agreement with Teijin Ltd, regarding JTR-161, an allogeneic regenerative medical product using dental pulp stem cells (DPCs) for the indication of acute cerebral infarction (stroke) for Japan, on July 18
* Teijin invests in its twaron capacity in Dutch production facility
* Radius Health announces license and development agreement for Abaloparatide-Sc with Teijin Limited in Japan
* Says it lowered the conversion price for 2018 due euro-yen denominated convertible bonds and 2021 due euro-yen denominated convertible bonds to 2,035.7 yen per share and 2,001.3 yen per share respectively, from 2,063.5 yen per share and 2,028.6 yen per share, effective...
* Says it plans to sell 100 percent stake of shares in its two US-based home healthcare units Braden Partners, L.P and Associated Healthcare Systems, Inc, on April 27 (US local time)
* Japan's Teijin planning $18 million air bag fabric plant in Vietnam - Nikkei Source text for Eikon: Further company coverage:
* Nativis enters into exclusive licensing agreement for Glioblastoma Multiforme in Japan
* Says the co plans to set up new unit on July 3, to take over part of medical business from the co
* Says it adjusted the conversion price for 2018 due euro-yen denominated convertible bonds to 2,063.5 yen per share, from 2,069.0 yen per share, effective Oct. 1
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.